Cargando…
miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q
Cognitive impairment in Alzheimer’s disease (AD) is usually accompanied by synaptic loss in both the hippocampus and neocortex. In the early stage of AD, amyloid β-induced synapse changes is the main reason, while in the later stage, the accumulation of Tau protein promotes synapse degeneration as t...
Autores principales: | Xu, Nan, Li, Ang-Di, Ji, Li-Li, Ye, Yao, Wang, Zhen-Yu, Tong, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511887/ https://www.ncbi.nlm.nih.gov/pubmed/31060348 http://dx.doi.org/10.4081/ejh.2019.3008 |
Ejemplares similares
-
Synaptic Changes in the Dentate Gyrus of APP/PS1 Transgenic Mice Revealed by Electron Microscopy
por: Alonso-Nanclares, Lidia, et al.
Publicado: (2013) -
Studies on APP metabolism related to age-associated mitochondrial dysfunction in APP/PS1 transgenic mice
por: Chen, Lizhi, et al.
Publicado: (2019) -
SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease
por: Hadar, A., et al.
Publicado: (2018) -
Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition
por: Zhao, Peng, et al.
Publicado: (2019) -
Transgenic miR132 Alters Neuronal Spine Density and Impairs Novel Object Recognition Memory
por: Hansen, Katelin F., et al.
Publicado: (2010)